
Afton Scientific is a contract manufacturing organization (CMO) in Virginia that specializes in small-batch filling of injectables from clinical trials to approved commercial drugs.
Utilizing 35,000 Sq. Ft of manufacturing, lab, warehouse, and administrative space, Afton provides custom, innovative solutions for clinical to commercial sterile manufacturing, packaging and labeling, analytical and micro lab services, and pharmaceutical support services.
Our Ready-To-Fill® line continues with our philosophy of guidance and support for our clients. It offers top-quality pre-sterilized components to those who can fill in-house.
NOTE: Afton Scientific does not sponsor work visas. No recruiters please.
Pay Details: Non-exempt position, range of $25 - $30 per hour, depending on level of experience.
Knowledge, Skills & Abilities
Requirements for Education and Experience

Afton Scientific is a Charlottesville, Virginia–based contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceuticals. For over 20 years, the company has partnered with global pharmaceutical and biotech innovators to provide aseptic processing, small- and mid-batch vial filling, and advanced fill/finish services from clinical trials through commercial supply.
Operating from FDA-inspected, cGMP facilities with isolator-based Grade A/Class 100 environments, Afton Scientific focuses on biologics, small molecules, and emerging modalities, including mRNA and other novel injectables. Its integrated capabilities span formulation support, sterile filling, packaging and labeling, plus in-house analytical and microbiology laboratories designed to streamline timelines and strengthen regulatory compliance.
Guided by a commitment to quality, reliability, and innovation, Afton Scientific maintains a strong inspection record with U.S. and global health authorities and a robust Quality Management System built around continuous improvement. Backed by a multi-year growth roadmap and strategic investment, the company is expanding capacity with new pre-filled syringe and cartridge lines and an additional facility that will add hundreds of high-skill jobs while supporting the next generation of sterile injectable therapies.